Baltimore, MD: A significant percentage Topical CBD products derived from hemp contain percentages of CBD and THC that differ significantly from what appears on their packaging, according to data published in the journal JAMA Network Open.
A team of researchers affiliated with John Hopkins University School of Medicine and the Substance Abuse and Mental Health Services Administration evaluated the purity of 105 commercially available hemp-derived CBD topical products.
Of the 89 products that provided information on the percentage of CBD available in them, only 24 percent provided accurate data. Thirty-five percent of topical products also tested positive for trace amounts of THC, including 11 percent of products that were explicitly labeled “THC-free.” (More than half of the products tested had no mention of THC on the product label.)
The findings are consistent with dozens of previous studies that similarly report that commercially available CBD products rarely provide accurate information on their packaging.
authors he concluded“This case series found that topical cannabinoid products purchased online and at popular retail stores were often mislabeled for CBD content and many contained the psychoactive cannabis constituent THC. In addition, some products make therapeutic claims for indications not approved by the FDA These findings highlight the need for adequate regulatory oversight of cannabis and hemp products to ensure that these products meet established standards for quality assurance and that the consumers are not misled by unproven therapeutic or cosmetic claims”.
More than three years after the passage of federal legislation legalizing the production of hemp, the US Food and Drug Administration (FDA) has yet to promulgate rules governing the marketing and sale of commercial products containing CBD derived from hemp or other cannabinoids. Survey data compiled by the National Consumers League previously determined that more than eight in ten American voters want greater federal regulatory oversight over the labeling and marketing of commercially available CBD products.
The full text of the study, “Cannabinoid Content and Label Accuracy of Hemp-Derived Topical Products Available Online and in National Retail Stores,” appears in JAMA Network Open.
Like this:
Loading…